{"id":"doi:10.1056/nejmoa2107519","kind":"article","title":"Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes","authors":["Juan P. Frías","Melanie Jane Davies","Julio Rosenstock","Federico Pérez Manghi","Laura Fernández Landó","Brandon K. Bergman","Bing Liu","Xuewei Cui","Katelyn E. Brown"],"author_count":9,"year":2021,"published":"2021-06-25","venue":"New England Journal of Medicine","cited_by":2086,"doi":"10.1056/nejmoa2107519","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1056/nejmoa2107519","archive_url":"https://space-kitty.com/papers/doi:10.1056/nejmoa2107519","updated":null,"pmid":"34170647","pmcid":null,"openalex_id":"W3177122952","pdf_url":null,"abstract":null,"abstract_license":null,"license":null,"is_open_access":true,"retracted":false,"peer_reviewed":null,"categories":["Diabetes Treatment and Management"],"details":null,"provenance":"openalex","attribution":"Metadata and citation counts: OpenAlex (CC0).","topics":[{"slug":"glp1-metabolic","name":"GLP-1 & Incretin Therapies","domain_slug":"medicine"}],"cited_in_dossiers":[{"slug":"glp1-metabolic","title":"GLP-1 & Incretin Therapies: State of the Field (October 2026)","url":"https://space-kitty.com/dossiers/glp1-metabolic"}]}